Skip to Main Content

Paper Details

Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality.
J Clin Invest
54
2021
2, COVID-19, COVID-19 infection, CoV2, CoV2 spike protein, CoV2 spike protein peptides, CoV2 spike receptor binding domain, HCoV, HCoV spike peptides, SARS, SARS-CoV-2, alphacoronavirus, convalescent plasma, endemic human coronavirus (HCoV) genomes, human, hyperimmune globulin, plasma
Author NameAffiliation
Evan M BlochJohns Hopkins University School of Medicine
Ingo Ruczinski
Shmuel ShohamJohns Hopkins University School of Medicine
Arturo CasadevallJohns Hopkins University Bloomberg School of Public Health
Arturo CasadevallJohns Hopkins University Bloomberg School of Public Health
Oliver LaeyendeckerJohns Hopkins University School of Medicine
Oliver LaeyendeckerNational Institute of Allergy and Infectious Diseases (NIAID)
Andrew PekoszJohns Hopkins University Bloomberg School of Public Health
Stephen J ElledgeHoward Hughes Medical Institute, Brigham and Women's Hospital, Harvard Medical School
Aaron A R TobianJohns Hopkins University School of Medicine
Harry Benjamin LarmanInstitute for Cell Engineering, Johns Hopkins University School of Medicine
  • 1 - 11

Datasets

Release 1.2